Artificial intelligence (AI) is not a godsend or a panacea, but a technology, literally a tool that enhances human skill beyond its physical limits, capable of processing and drawing insights from more data than you or I could comb over across multiple lifetimes. Consequently, AI is not trying to replace the human touch, but enhance it.
This article is disseminated in partnership with AI stocks Aether Holdings Inc. and MedPal AI PLC. It is intended to inform investors and should not be taken as a recommendation or financial advice.
Investors keen on increasing their exposure to the space should take heed from this line of thought, quickly discarding companies under the impression that consciousness, as of yet still largely misunderstood, is on the verge of being superseded by the defaced responses of AI-powered customer service agents, or whatever your last Google Gemini prompt turned up, turning their attention instead to companies who haven’t forgotten that technology only leads to a revolution if it makes our lives better in some sustainable long-term way.
The spotlight companies in the newest edition of Stockhouse’s Weekly Market Movers certainly see it this way, deploying AI in the service of solving some of our most pressing problems – how to be healthier and how to invest optimally – as opposed to buying into the apocalyptic sentiment that always follows innovation attractive enough to change our everyday lives.
Aether Holdings
Our first stock riding the humanist side of the AI tailwind is New-York-based Aether Holdings, market cap US$43.61 million, whose mission is to marry AI and financial technology to help investors more easily access, analyze and capitalize on market information. The company closes the gap between stuffing your cash under your mattress and informed decision-making through three main offerings:
- Aether Edge Media, which curates financial media into actionable insights, including nine in-house newsletter properties — among them Coinstack, 21Bitcoin, The Russell Report, IPO Stream, WhaleTales and SentimenTracker — combining for more than 400,000 subscribers.
- Aether Grid, a proprietary AI analytics engine designed to identify market trends.
- Aether Lab, a space to innovative and test decentralized financial technologies.
This lineup was recently expanded with OpenTicker, an open-source framework to help traders build and manage workflows across all asset classes, and Alphid.ai, effectively a custom Chief Research Officer for retail investors that autonomously analyzes fundamentals, technical signals, sentiment indicators and macro figures to come to risk-adjusted conclusions.
Aether’s tech-forward approach enables a sound financial strategy built on diversified revenue streams, including software-as-a-service, licensing, data/API sales, advertising and
sponsorships, positioning the company to rapidly cruise up its path to profitability as it attains greater scale.
The company connects the dots across its investor-centric operation with a leadership team that pairs decades of global markets experience with decades of software, Internet of Things and AI experience, including specializations in M&A, business restructuring and technology law, granting it a deep problem-solving ability more likely to exploit than cower in the face of market volatility.
Aryan Liaghat, Head of Product at Aether Holdings, spoke with Ricki Lee about the ins and outs of Alphid.ai. Watch the interview here.
Aether Holdings stock (NASDAQ:ATHR) last traded at US$3.61 and has given back 77.66 per cent year-over-year.
MedPal AI
Our second AI stock promoting human flourishing, as opposed to substitution, is UK-based MedPal AI, market cap £14.47 million, whose AI-powered app aggregates data from wearable fitness trackers and health apps, including Apple Health, Google Fit, Whoop, Fitbit and Garmin, into a unified profile to optimize wellness management through personalized recommendations.
The company addresses several unmet needs in the digital health and wellness space, including the need for a wholistic picture of how well you’re taking care of yourself, a reliable means of deriving actionable insights without professional help, as well as a reliable means of proactive monitoring, with a group of specialized AI agents constantly crunching numbers in the background to assess risks and suggest bio-hacks as you go about your day.
MedPal complements its app with automated NHS-contracted dispensing hubs in Runcorn and Swaffham, backed by distance selling pharmacy licenses, which are currently handling more than 40,000 prescriptions per month – a scale reached after only five months in business – connecting patient engagement, clinical services and pharmacy fulfilment under a single platform as part of the company’s broader mission to build an operating system for personal health.
New Health, the latest expansion within this system, is a sub-brand created to educate consumers on GLP-1 weight management and capitalize on the peptide medicine opportunity, leveraging direct supply agreements with Eli Lilly and Novo Nordisk.
At the helm, MedPal’s mission is in the hands of a management team as comfortable scaling technology companies as it is saving lives on the operating table, equipping the company with the real-world experience required to harness AI to add value within its target markets.
The company expects to break even at around 75,000 monthly prescriptions, with month-over-month growth exceeding 27 per cent as of April 2026, putting profitability within sight.
Jason Drummond, Chief Executive Officer of MedPal, joined our Ricki Lee for a chat about the intricacies of the company’s consumer-facing strategy. Watch the interview here.
MedPal AI stock (LSE:MPAL) last traded at £2.38 and has given back 63.46 per cent since inception in August 2025.
Thanks for reading! I’ll see you next Monday for a new edition of Weekly Market Movers, where I delve into companies that joined Stockhouse for an interview over the past week. Here’s the most recent article, in case you missed it.
Join the discussion: Find out what investors are saying about these AI stocks on the Aether Holdings Inc. Bullboard on Stockhouse and the MedPal AI PLC Discussion Thread on ADVFN.